In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including legal challenges to the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, HHS, Medicare, drug prices

Source Links: 

• Merck sues to block Medicare negotiation of drug prices 
• Bristol Myers follows Merck's lead with its own ⁠lawsuit blasting IRA's Medicare negotiations 
• PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures 
• Explaining the Prescription Drug Provisions in the Inflation Reduction Act 
• Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026: Moody's 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at  

1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

Mindy.McGrath@vynamic.com

Ryan Hummel, Executive and Head of Provider Sector 

Ryan.Hummel@vynamic.com

Jen Burke, Director 

Jen.Burke@vynamic.com